Showing 811-820 of 1010 results for "".
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://modernaesthetics.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- 2025 AAD: Drs. Shino Bay Aguilera, Michael Somenek Face Off Over Filler Treatmentshttps://modernaesthetics.com/news/2025-aad-drs-shino-bay-aguilera-michael-somenek-face-off-over-filler-treatments/2473759/A ticketed session at the 2025 American Academy of Dermatology (AAD) Annual Meeting brought together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural
- 2025 AAD: Treating Hyperpigmented and Hypertrophic Scars with Microneedling in Skin of Colorhttps://modernaesthetics.com/news/2025-aad-treating-hyperpigmented-and-hypertrophic-scars-with-microneedling-in-skin-of-color/2473758/Robyn Siperstein, MD, FAAD, presented “Use of Microneedling in Skin of Color: Treating Hyperpigmented and Hypertrophic Scars” at the 2025 American Academy of Dermatology Annual Meeting Sunday. “The key to this treatment and how I’ve really changed my anti-aging treatments are two things:
- New Solution to Alleviate Challenges from Denied Insurance Claims Unveiledhttps://modernaesthetics.com/news/new-solution-to-alleviate-challenges-from-denied-insurance-claims-unveiled-1/2473757/A new solution to alleviate the challenges posed by insurance claim denials and make it easier for providers to salvage denied claims and increase their reimbursement was on display at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, as Nextech previewed the late
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with
- Martha Stewart Discusses BOTOX for Platysma Bandshttps://modernaesthetics.com/news/martha-stewart-discusses-botox-for-platysma-bands/2473750/BOTOX Cosmetic’s platysma bands indication has a fan in Martha Stewart. The keynote speaker at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, said she visits her dermatologist “once every couple months.” Gesturing to her jaw and neck, Stewart said she ge
- 2025 AAD Meeting: The Power of Social Media in Dermatology to Educate, Engage, and Inspirehttps://modernaesthetics.com/news/2025-aad-meeting-the-power-of-social-media-in-dermatology-to-educate-engage-and-inspire/2473749/Combatting misinformation that is spread on social media was one of the session topics at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida on Friday. Among the speakers was Lindsey Zubritsky, MD, FAAD, or the dermguru, as she’s known on social media. Dr. Zubritsky’s lec
- Closing the Healthcare Gender Gap as a Key to Optimize Female Longevityhttps://modernaesthetics.com/news/closing-the-healthcare-gender-gap-as-a-key-to-optimize-female-longevity/2473748/"The story of women's struggle for equality belongs to no single feminist nor to any one organization but to the collective efforts of all who care about human rights." —Gloria Steinem The United Nations has declared the theme for this year’s International
- LaserAway, Rejuran Partner to Bring Leading South Korea Skin Booster to UShttps://modernaesthetics.com/news/laseraway-rejuran-partner-to-bring-south-koreas-no-1-skin-booster-to-us-1/2473746/A leading South Korean salmon DNA-based treatment will soon be available in the US under a new partnership announced by Rejuran. LaserAway, an aesthetic practice with more than 175 locations across the country, will help drive Rejuran’s first major US market entry, according to a
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com